Avadel Pharmaceuticals plc (AVDL)
21.64
+0.01 (0.05%)
Inactive · Last trade price on Feb 11, 2026

Avadel Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-0.28-48.83-160.28-137.46-77.337.03
Depreciation & Amortization
3.682.681.771.490.821.69
Other Amortization
--2.86.051.256.52
Loss (Gain) From Sale of Assets
------45.76
Asset Writedown & Restructuring Costs
20-----
Stock-Based Compensation
18.5620.3915.817.018.873
Other Operating Activities
-0.82-0.8314.3928.07-14.61-6.89
Change in Accounts Receivable
-5.34-21.99-12.1--8.28
Change in Inventory
-8.01-9.22-9.53---1.35
Change in Accounts Payable
4.49-4.091.55-3.114.23-2.79
Change in Other Net Operating Assets
2.2714.9917.0927.64-0.54-18.47
Operating Cash Flow
34.54-46.91-128.51-70.3-77.31-48.73
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Capital Expenditures
-0.19---0.72-0.03-0.1
Divestitures
----16.525.5
Sale (Purchase) of Intangibles
-15-----
Investment in Securities
25.7351.78-50.0980.4140.46-95.12
Investing Cash Flow
10.5451.78-50.0979.756.93-69.72

Financing Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Long-Term Debt Repaid
---38.67-8.65--
Net Debt Issued (Repaid)
---38.67-8.65--
Issuance of Common Stock
5.0615.97148.36280.26179.68
Other Financing Activities
--25.64-4.8--
Financing Cash Flow
5.0615.97135.3414.540.26179.68

Net Cash Flow

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Foreign Exchange Rate Adjustments
1.09-0.640.46-0.66-0.90.72
Net Cash Flow
51.2320.2-42.8123.27-21.0161.95

Free Cash Flow

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Free Cash Flow
34.35-46.91-128.51-71.02-77.34-48.83
Free Cash Flow Growth
------
Free Cash Flow Margin
13.82%-27.74%-459.57%---218.64%
Free Cash Flow Per Share
0.35-0.49-1.60-1.18-1.32-0.89
Levered Free Cash Flow
2.73-30.37-78.68-25.39-38.03-57.42
Unlevered Free Cash Flow
8.8-23.6-75.3-23.73-33.07-55.83

Additional Metrics

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash Interest Paid
10.297.185.259.666.476.47
Cash Income Tax Paid
----29.060.08-1.7
Change in Working Capital
-6.59-20.32-324.543.7-14.32
SEC Filings: 10-K · 10-Q